Abstract:Antimicrobial resistance (AMR) poses a serious global health concern, resulting in a significant number of deaths annually due to infections that are resistant to treatment. Amidst this crisis, antimicrobial peptides (AMPs) have emerged as promising alternatives to conventional antibiotics (ATBs). These cationic peptides, naturally produced by all kingdoms of life, play a crucial role in the innate immune system of multicellular organisms and in bacterial interspecies competition by exhibiting broad-spectrum activity against bacteria, fungi, viruses, and parasites. AMPs target bacterial pathogens through multiple mechanisms, most importantly by disrupting their membranes, leading to cell lysis. However, bacterial resistance to host AMPs has emerged due to a slow co-evolutionary process between microorganisms and their hosts. Alarmingly, the development of resistance to last-resort AMPs in the treatment of MDR infections, such as colistin, is attributed to the misuse of this peptide and the high rate of horizontal genetic transfer of the corresponding resistance genes. AMP-resistant bacteria employ diverse mechanisms, including but not limited to proteolytic degradation, extracellular trapping and inactivation, active efflux, as well as complex modifications in bacterial cell wall and membrane structures. This review comprehensively examines all constitutive and inducible molecular resistance mechanisms to AMPs supported by experimental evidence described to date in bacterial pathogens. We also explore the specificity of these mechanisms toward structurally diverse AMPs to broaden and enhance their potential in developing and applying them as therapeutics for MDR bacteria. Additionally, we provide insights into the significance of AMP resistance within the context of host–pathogen interactions.

Bacteria Resistance to Antimicrobial Peptides and It's Mechanism

Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides in the Modern Era: An Updated Review

Antimicrobial peptides for combating drug-resistant bacterial infections

Resistance Mechanisms to Antimicrobial Peptides in Gram-Positive Bacteria

Mechanisms of Action, Biological Characteristics, and Future Prospects: A Review of Antimicrobial Peptides (A Review)

Bioactivity, Action Mechanism and Application of Antimicrobial Peptides

Antimicrobial peptides: mechanism of action, activity and clinical potential

Antimicrobial Peptides: From Design to Clinical Application

Antimicrobial Peptides and Their Biomedical Applications: A Review

Antimicrobial Peptides (AMPs): Roles, Functions and Mechanism of Action

Classification, Sources, and Mechanism of Action against Multidrug-Resistant Bacteria

Mechanism of Antimicrobial Peptides: Antimicrobial, Anti-Inflammatory and Antibiofilm Activities

Mechanisms of Antimicrobial Peptide Action and Resistance

Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo

Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era

Antimicrobial peptides: Opportunities and challenges in overcoming resistance

Fundamentals on the molecular mechanism of action of antimicrobial peptides

Diversity and Mechanisms of Action of Plant, Animal, and Human Antimicrobial Peptides

Antimicrobial peptide-based strategies to overcome antimicrobial resistance

Antimicrobial Peptides and Cell-Penetrating Peptides: Non-Antibiotic Membrane-Targeting Strategies Against Bacterial Infections

Antimicrobial Mechanisms and Clinical Application Prospects of Antimicrobial Peptides